Lataa...
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
Toshikazu YamanouchiKita-Tokyo-Jueien/Department of Internal Medicine, Teikyo University, Tokyo, JapanAbstract: To prevent hyperinsulinemia, which may cause atherosclerosis, thiazolidinediones (TZDs), also known as insulin sensitizers, are often added to the therapeutic regimen of patients with type...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2010-03-01
|
| Sarja: | Vascular Health and Risk Management |
| Linkit: | http://www.dovepress.com/concomitant-therapy-with-pioglitazone-and-insulin-for-the-treatment-of-a4122 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|